CVS is facing legal action from the U.S. Department of Justice over illegal opioid prescription and billing practices.
TD Cowen keeps a Buy rating and $80 price target on CVS. The firm says the DOJ complaint relating to opioid prescriptions is incremental to ...
The Justice Department has unsealed a civil complaint alleging CVS Pharmacy Inc. and various subsidiaries filled unlawful ...